Anti-fibrotic effects of nintedanib on lung fibroblasts derived from patients with Progressive Fibrosing Interstitial Lung Diseases (PF-ILDs)
Audrey Joannes, T. Voisin, Claudie Morzadec, Alice Letellier, Francisco Llamas Gutierrez, Dan Cristian Chiforeanu, Cécile Le Naourès, Stéphanie Guillot, Bertrand Richard De Latour, Simon Rouzé, Madeleine Jaillet, Bruno Crestani, Lutz Wollin, S. Jouneau, Laurent Vernhet
Topics & Concepts
NintedanibIdiopathic pulmonary fibrosisPlatelet-derived growth factor receptorPulmonary fibrosisFibrosisMedicineInterstitial lung diseaseLungCancer researchPathologyInternal medicineReceptorGrowth factorInterstitial Lung Diseases and Idiopathic Pulmonary FibrosisSarcoidosis and Beryllium Toxicity ResearchOccupational exposure and asthma